9
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      International Journal of COPD (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on pathophysiological processes underlying Chronic Obstructive Pulmonary Disease (COPD) interventions, patient focused education, and self-management protocols. Sign up for email alerts here.

      39,063 Monthly downloads/views I 2.893 Impact Factor I 5.2 CiteScore I 1.16 Source Normalized Impact per Paper (SNIP) I 0.804 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Poor outcome of laparoscopic cholecystectomy in patients with COPD: how determinant it is? [Letter]

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear editor We have read the study by Liao et al published in your journal with great interest.1 The article evaluates the effects of COPD on the outcome of laparoscopic cholecystectomy. Although COPD is a well-known risk for postoperative pulmonary complications, it is interesting to know this association from this matched study with a relatively larger sample. The authors' findings and conclusions are relevant, but we consider that a few other aspects need to be taken into account from the practical point of view. Firstly, from the methodological point of view, although the cohort was matched for age and gender, their comorbidities were very much different and may have affected the outcome measures like use of supports, ie, vasopressors, hemodialysis (HD), mechanical ventilation (MV), intensive care unit (ICU) stay, etc. Inclusion of patients with only COPD in the COPD group or using multivariate analysis may have helped in determining the real impact caused by COPD. In addition, the time period considered, ie, 1997–2013, is too long and the management strategy, especially for COPD patients, has evolved/changed a lot, diluting the applicability in the current practice. Secondly, the information on intraoperative and postoperative respiratory management is very crucial and is missing. Respiratory management in hypercapnic, emphysema patient during pneumoperitoneum, use of multimodal analgesia, especially regional analgesia techniques, neuromuscular blockade management can impact the postoperative pulmonary conditions and outcome. Similarly, preoperative optimization strategy for risk reduction taken, induction of COPD specific treatment, if any, is also equally important.2–4 Finally, information on whether the facility of HD, MV, ICU were there in all the hospitals included is critical. It is because, it can lead to a selection bias, management differences, as well as impact in the outcome. A recent meta-analysis indicates that laparoscopic major gastrointestinal surgery in COPD patients is safe and has its own benefits including reduced overall postoperative pulmonary complications.5 However, proper patient selection is very important.5 While we very much welcome and accept the conclusion of the authors, we believe that the bad prognosis, ie, increased mortality and mechanical ventilation, shown and attributed to COPD needs to be judged in the above perspective too. Future study will be required to find out the impact of current management of COPD, its attribution toward postoperative mortality and subgroup of COPD patients who are more vulnerable.

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Risk factors of postoperative pulmonary complications in patients with asthma and COPD

          Background Postoperative pulmonary complications (PPC) in patients with pulmonary diseases remain to be resolved clinical issue. However, most evidence regarding PPC has been established more than 10 years ago. Therefore, it is necessary to evaluate perioperative management using new inhalant drugs in patients with obstructive pulmonary diseases. Methods April 2014 through March 2015, 346 adult patients with pulmonary diseases (257 asthma, 89 chronic obstructive pulmonary disease (COPD)) underwent non-pulmonary surgery except cataract surgery in our university hospital. To analyze the risk factors for PPC, we retrospectively evaluated physiological backgrounds, surgical factors and perioperative specific treatment for asthma and COPD. Results Finally, 29 patients with pulmonary diseases (22 asthma, 7 COPD) had PPC. In patients with asthma, smoking index (≥ 20 pack-years), peripheral blood eosinophil count (≥ 200/mm3) and severity (Global INitiative for Asthma(GINA) STEP ≥ 3) were significantly associated with PPC in the multivariate logistic regression analysis [odds ratio (95% confidence interval) = 5.4(1.4–20.8), 0.31 (0.11–0.84) and 3.2 (1.04–9.9), respectively]. In patients with COPD, age, introducing treatment for COPD, upper abdominal surgery and operation time (≥ 5 h) were significantly associated with PPC [1.18 (1.00–1.40), 0.09 (0.01–0.81), 21.2 (1.3–349) and 9.5 (1.2–77.4), respectively]. Conclusions History of smoking or severe asthma is a risk factor of PPC in patients with asthma, and age, upper abdominal surgery, or long operation time is a risk factor of PPC in patients with COPD. Adequate inhaled corticosteroids treatment in patients with eosinophilic asthma and introducing treatment for COPD in patients with COPD could reduce PPCs.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Chronic obstructive pulmonary disease and anaesthesia

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Anesthetic considerations in the patients of chronic obstructive pulmonary disease undergoing laparoscopic surgeries

              The aim of this study was to review the various anesthetic options which can be considered for laparoscopic surgeries in the patients with the chronic obstructive pulmonary disease. The literature search was performed in the Google, PubMed, and Medscape using key words “analgesia, anesthesia, general, laparoscopy, lung diseases, obstructive.” More than thirty-five free full articles and books published from the year 1994 to 2014 were retrieved and studied. Retrospective data observed from various studies and case reports showed regional anesthesia (RA) to be valid and safer option in the patients who are not good candidates of general anesthesia like patients having obstructive pulmonary diseases. It showed better postoperative patient outcome with respect to safety, efficacy, postoperative pulmonary complications, and analgesia. So depending upon disease severity RA in various forms such as spinal anesthesia, paravertebral block, continuous epidural anesthesia, combined spinal epidural anesthesia (CSEA), and CSEA with bi-level positive airway pressure should be considered.
                Bookmark

                Author and article information

                Journal
                Int J Chron Obstruct Pulmon Dis
                Int J Chron Obstruct Pulmon Dis
                COPD
                copd
                International Journal of Chronic Obstructive Pulmonary Disease
                Dove
                1176-9106
                1178-2005
                12 September 2019
                2019
                : 14
                : 2131-2132
                Affiliations
                [1 ]Department of Anaesthesia, AIIMS Raipur , Raipur, India
                [2 ]ICU, Hospital Morales , Murcia, Spain
                Author notes
                Correspondence: Subrata Kumar SinghaDepartment of Anaesthesia, AIIMS , 3rd Floor, Major OT, Trauma Building, PO: Tatibandh, Raipur492099, CG, IndiaEmail subratsingh@gmail.com
                Article
                222557
                10.2147/COPD.S222557
                6746304
                e06e4b46-d4fe-4ef4-bbff-4d8f05ac9224
                © 2019 Singha et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 09 July 2019
                : 01 August 2019
                Page count
                References: 5, Pages: 2
                Categories
                Letter

                Respiratory medicine
                Respiratory medicine

                Comments

                Comment on this article